Bobbi Pritt, M.D., explains how Mayo Clinic Laboratories' new assay identifies less-common tick-borne bacteria in whole blood. The assay is recommended when tick-borne bacterial infection is suspected but standard testing is unrevealing.

(00:33)
 Do you mind giving us a brief introduction of yourself and what you do at Mayo?

 

(01:45)
 Can you tell us a little about the test and how it came to be?

 

(03:00)
 Could you explain the types of patients this test would be best suited for and how a provider might determine if their patient would benefit from this?

 

(03:32)
 Would you please explain why the algorithm is recommended and where in the algorithm this test fits?

 

(04:36)
 What makes this test different from what's currently available to providers?

 

(05:38)
 How can the information be used in patient care? And can you talk a little bit about how the diagnosis can be clarified by using this assay, why it's important, and how the results would impact a patient's care and treatment plan?